Company intelligence / Profile preview

Cellphire Therapeutics, Inc.

Rockville, Maryland, United Statescellphire.com ↗

Ownership: Private
Development stage: Phase 2

Overview

Cellphire has two products in Phase 2 clinical trials: CLPH-511 (Cryopreserved Platelets/CPP) and CLPH-211 (Freeze-dried Platelet-derived Hemostat/FPH). The CRYPTICS Phase 2/3 clinical study for CLPH-511 was stopped early for efficacy following pre-planned interim analysis. In March 2025, CLPH-511 received Fast Track designation from the FDA for treatment of acute hemorrhage. A Phase 2 clinical trial of Thrombosomes (FPH) in Acute Aortic Dissections completed enrollment of 41 patients ahead of schedule in June 2024.

Therapeutic areas: CardiovascularRheumatologyOtherHematologyNeurology
Modalities: Platelet-derived therapiesStabilized cellular therapeuticsAllogeneic platelet-derived cellular therapeutics
Industry: Biotech

Drug pipeline

8 assets

cryopreserved platelets

7 more assets in the full pipeline.

Partnerships

Biomedical Advanced Research and Development Authority (BARDA)Defense Advanced Research Projects Agency (DARPA)United States Special Operations Command (USSOCOM)United States Army Medical Research Acquisition Activity (USAMRAA)Medical Technology Enterprise Consortium (MTEC)

Beyond the preview

Go deeper on Cellphire Therapeutics, Inc..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cellphire Therapeutics, Inc..